Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial (Q95728464)
Jump to navigation
Jump to search
scientific article published in January 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial |
scientific article published in January 2020 |
Statements
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial (English)
Walter Ageno
Irene Schmidtmann
Rupert M Bauersachs
Cecilia Becattini
Enrico Bernardi
Luca Bonacchini
Johannes Brachmann
Michael Christ
Michael Czihal
Daniel Duerschmied
Klaus Empen
Christine Espinola-Klein
Joachim H Ficker
Cândida Fonseca
Sabine Genth-Zotz
David Jiménez
Veli-Pekka Harjola
Matthias Held
Lorenzo Iogna Prat
Tobias J Lange
Athanasios Manolis
Andreas Meyer
Pirjo Mustonen
Ursula Rauch-Kroehnert
Pedro Ruiz-Artacho
Sebastian Schellong
Martin Schwaiblmair
Raoul Stahrenberg
Peter E Westerweel
Philipp S Wild
Stavros V Konstantinides
Mareike Lankeit
HoT-PE Investigators